2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 | Diabetes Care | American Diabetes Association [Internet]. [cited 2025 Aug 19]. Available from: https://diabetesjournals.org/care/article/47/Supplement_1/S20/153954/2-Diagnosis-and-Classification-of-Diabetes

Rooney MR, Fang M, Ogurtsova K, Ozkan B, Echouffo-Tcheugui JB, Boyko EJ, et al. Global prevalence of prediabetes. Diabetes Care. 2023;46:1388–94.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yip WCY, Sequeira IR, Plank LD, Poppitt SD. Prevalence of pre-diabetes across ethnicities: a review of impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) for classification of dysglycaemia. Nutrients. 2017;9:1273.

Article  PubMed  PubMed Central  Google Scholar 

Anjana RM, Deepa M, Pradeepa R, Mahanta J, Narain K, Das HK, et al. Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR-INDIAB population-based cross-sectional study. Lancet Diabetes Endocrinol. 2017;5:585–96.

Article  PubMed  Google Scholar 

An X, Zhang Y, Sun W, Kang X, Ji H, Sun Y, et al. Early effective intervention can significantly reduce all-cause mortality in prediabetic patients: a systematic review and meta-analysis based on high-quality clinical studies. Front Endocrinol. 2024;15:1294819.

Article  Google Scholar 

Abdul-Ghani MA, Tripathy D, DeFronzo RA. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care. 2006;29:1130–9.

Article  CAS  PubMed  Google Scholar 

Weyer C, Bogardus C, Pratley RE. Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. Diabetes. 1999;48:2197–203.

Article  CAS  PubMed  Google Scholar 

Rhee SY, Woo J-T. The prediabetic period: review of clinical aspects. Diabetes Metab J. 2011;35:107–16.

Article  PubMed  PubMed Central  Google Scholar 

Unwin N, Shaw J, Zimmet P, Alberti KGMM. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med. 2002;19:708–23.

Article  CAS  PubMed  Google Scholar 

Bartel DP. Micrornas: target recognition and regulatory functions. Cell. 2009;136:215–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

miRNAs as biomarkers in disease: latest findings regarding their role in diagnosis and prognosis–PMC [Internet]. [cited 2025 Aug 19]. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC7072450/

Vasu S, Kumano K, Darden CM, Rahman I, Lawrence MC, Naziruddin B. Microrna signatures as future biomarkers for diagnosis of diabetes states. Cells. 2019;8:1533.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zeinali F, Aghaei Zarch SM, Jahan-Mihan A, Kalantar SM, Vahidi Mehrjardi MY, Fallahzadeh H, et al. Circulating microRNA-122, microRNA-126-3p and microRNA-146a are associated with inflammation in patients with pre-diabetes and type 2 diabetes mellitus: a case control study. PLoS ONE. 2021;16:e0251697.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Circulating microRNA changes in patients with impaired glucose regulation - PubMed [Internet]. [cited 2025 Aug 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/32752917/

Misra P, V. AS, R. P, K. K, Vashum Y, G. R, et al. Circulatory levels of multiple microrna associated with prediabetes. Int J Diabetes Dev Ctries. 2023;43:1043–51.

Article  CAS  Google Scholar 

Ramaswamy P, Christopher R, Kumar Pal P, Debnath M, Yadav R. Plasma microRNAs as a potential biomarker for identification of progressive supranuclear palsy. Diagnostics. 2022;12:1204.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ghafouri-Fard S, Khoshbakht T, Hussen BM, Jamal HH, Taheri M, Hajiesmaeili M. A comprehensive review on function of miR-15b-5p in malignant and non-malignant disorders. Front Oncol. 2022. https://doi.org/10.3389/fonc.2022.870996/full.

Article  PubMed  PubMed Central  Google Scholar 

Vickers KC, Shoucri BM, Levin MG, Wu H, Pearson DS, Osei-Hwedieh D, et al. MicroRNA-27b is a regulatory hub in lipid metabolism and is altered in dyslipidemia. Hepatology. 2013;57:533–42.

Article  CAS  PubMed  Google Scholar 

Benito-Vicente A, Uribe KB, Rotllan N, Ramírez CM, Jebari-Benslaiman S, Goedeke L, et al. miR-27b modulates insulin signaling in hepatocytes by regulating insulin receptor expression. Int J Mol Sci. 2020;21:8675.

Article  CAS  PubMed  PubMed Central  Google Scholar 

MicroRNA-142 regulates inflammation and T cell differentiation in an animal model of multiple sclerosis | Journal of Neuroinflammation | Full Text [Internet]. [cited 2025 Aug 19]. Available from: https://jneuroinflammation.biomedcentral.com/articles/https://doi.org/10.1186/s12974-017-0832-7

Sidorkiewicz I, Niemira M, Maliszewska K, Erol A, Bielska A, Szalkowska A, et al. Circulating miRNAs as a predictive biomarker of the progression from prediabetes to diabetes: outcomes of a 5-year prospective observational study. J Clin Med. 2020;9:2184.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yazdanpanah Z, Kazemipour N, Kalantar SM, Vahidi Mehrjardi MY. Plasma miR-21 as a potential predictor in prediabetic individuals with a positive family history of type 2 diabetes mellitus. Physiol Rep. 2022;10:e15163.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Savage DB, Petersen KF, Shulman GI. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev. 2007;87:507–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hammad SM, Lopes-Virella MF. Circulating sphingolipids in insulin resistance, diabetes and associated complications. Int J Mol Sci. 2023;24:14015.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boucher J, Kleinridders A, Kahn CR. Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harb Perspect Biol. 2014;6:a009191.

Article  PubMed  PubMed Central  Google Scholar 

The hippo signaling pathway in pancreatic β-cells: functions and regulations–PubMed [Internet]. [cited 2025 Aug 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/29053790/

Pliszka M, Szablewski L. Associations between diabetes mellitus and selected cancers. Int J Mol Sci. 2024;25:7476.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity–PMC [Internet]. [cited 2025 Aug 19]. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC5819359/

Luna R, TalankiManjunatha R, Bollu B, Jhaveri S, Avanthika C, Reddy N, et al. A comprehensive review of neuronal changes in diabetics. Cureus. 2021;13:e19142.

PubMed  PubMed Central  Google Scholar 

Huang X, Liu G, Guo J, Su Z. The PI3K/AKT pathway in obesity and type 2 diabetes. Int J Biol Sci. 2018;14:1483–96.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alemany M. Estrogens and the regulation of glucose metabolism. World J Diabetes. 2021;12:1622–54.

Article  PubMed  PubMed Central  Google Scholar 

Lemos JRN, Hirani K, von Herrath M. Immunological and virological triggers of type 1 diabetes: insights and implications. Front Immunol. 2023;14:1326711.

Article  CAS  PubMed  Google Scholar